Clinical Trial Update: Invega (Paliperidone) for the Treatment of Mania in Children and Adolescents Ages 6-17 With Bipolar Disorder [Phase 4]

View source ↗

Summary

Phase 4 trial update for paliperidone (Invega) in treating mania in children and adolescents with bipolar disorder. The study was terminated and results were po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• INVEGA (PALIPERIDONE)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Pediatric Bipolar Disorder | Phase 4 | Status: TERMINATED | Results posted: 2012-07-04